<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Health Sector | Bodo Burger</title><link>https://bodoburger.github.io/tag/health-sector/</link><atom:link href="https://bodoburger.github.io/tag/health-sector/index.xml" rel="self" type="application/rss+xml"/><description>Health Sector</description><generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><copyright>Bodo Burger 2021</copyright><lastBuildDate>Fri, 07 Apr 2017 00:00:00 +0000</lastBuildDate><image><url>https://bodoburger.github.io/images/logo_huf0189912a6c4c6fe87cd287c2a6e1211_3971_300x300_fit_lanczos_2.png</url><title>Health Sector</title><link>https://bodoburger.github.io/tag/health-sector/</link></image><item><title>Data Analysis for Helmholtz Zentrum München</title><link>https://bodoburger.github.io/project/2017-biomarker-helmholtz/</link><pubDate>Fri, 07 Apr 2017 00:00:00 +0000</pubDate><guid>https://bodoburger.github.io/project/2017-biomarker-helmholtz/</guid><description>
&lt;p>The goal of the project was to quantify the relative importance
of different metabolic pathways for coronary heart disease and type 2 diabetes.
We analyzed data from the &lt;a href="https://www.helmholtz-muenchen.de/kora">KORA study&lt;/a>
for which more than 15000 people are repeatedly medically examined since 1984.
The main features of the analysis were 47 different biomarkers (see the image above)
that represent different metabolic pathways.
Additionally we controlled for several personal characteristics like sex or age.
The target features were the incidence of the disease and
the time until the incidence.
Before the analysis missing data was imputed.
We modeled the data using a Cox proportional hazards model.
The &lt;em>case-cohort&lt;/em> study design &lt;span class="citation">(Barlow 1994)&lt;/span> was taken into account
by weighing the data according to &lt;span class="citation">Barlow et al. (1999)&lt;/span>
upon request of our project partners.
Because this weighing method is not supported
by the R package &lt;code>survival&lt;/code> &lt;span class="citation">(Therneau 2015)&lt;/span>
we had to implement the routine by ourselves.
The estimation of the relative contribution of different biomarkers
to the risk of the disease was done as proposed by &lt;span class="citation">Montonen et al. (2011)&lt;/span>.
Finally, estimations from multiple imputations had to be combined
following Rubin’s rules &lt;span class="citation">(Rubin 1987)&lt;/span>.&lt;/p>
&lt;p>A paper using the results from this project was published in March 2020
(&lt;a href="https://cardiab.biomedcentral.com/articles/10.1186/s12933-020-01003-w">Huth et al “Biomarker-defined pathways for incident type 2 diabetes and coronary heart disease”&lt;/a>).&lt;/p>
&lt;div id="references" class="section level2 unnumbered">
&lt;h2>References&lt;/h2>
&lt;div id="refs" class="references">
&lt;div id="ref-barlow1994robust">
&lt;p>Barlow, William E. 1994. “Robust Variance Estimation for the Case-Cohort Design.” &lt;em>Biometrics&lt;/em>. JSTOR, 1064–72.&lt;/p>
&lt;/div>
&lt;div id="ref-barlow1999analysis">
&lt;p>Barlow, William E, Laura Ichikawa, Dan Rosner, and Shizue Izumi. 1999. “Analysis of Case-Cohort Designs.” &lt;em>Journal of Clinical Epidemiology&lt;/em> 52 (12). Elsevier: 1165–72.&lt;/p>
&lt;/div>
&lt;div id="ref-montonen2011estimation">
&lt;p>Montonen, Jukka, Dagmar Drogan, Hans-Georg Joost, Heiner Boeing, Andreas Fritsche, Erwin Schleicher, Matthias B Schulze, and Tobias Pischon. 2011. “Estimation of the Contribution of Biomarkers of Different Metabolic Pathways to Risk of Type 2 Diabetes.” &lt;em>European Journal of Epidemiology&lt;/em> 26 (1). Springer: 29–38.&lt;/p>
&lt;/div>
&lt;div id="ref-rubin1987multiple">
&lt;p>Rubin, D.B. 1987. &lt;em>Multiple Imputation for Nonresponse in Surveys&lt;/em>. Wiley Series in Probability and Statistics. Wiley.&lt;/p>
&lt;/div>
&lt;div id="ref-survival-package">
&lt;p>Therneau, Terry M. 2015. &lt;em>A Package for Survival Analysis in S&lt;/em>. &lt;a href="https://CRAN.R-project.org/package=survival">https://CRAN.R-project.org/package=survival&lt;/a>.&lt;/p>
&lt;/div>
&lt;/div>
&lt;/div></description></item><item><title>German Healthcare System - Risk Selection and Two-tier Medicine</title><link>https://bodoburger.github.io/project/2014-german-healthcare-system/</link><pubDate>Tue, 26 Aug 2014 00:00:00 +0000</pubDate><guid>https://bodoburger.github.io/project/2014-german-healthcare-system/</guid><description/></item></channel></rss>